Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAINS: Ibuprofen for Prevention of Altitude Illness
NCT01171794Phase 3Completed
- Sponsor
- Stanford University
- Start
- Jul 2010
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute mountain sickness (AMS) comparing Ibuprofen with Placebo (2 arms). Primary endpoints: Acute Mountain Sickness Incidence at 2 days and Acute Mountain Sickness Severity at 2 days. Started Jul 2010; status: completed.
02
Drugs
ibuprofen
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT01171794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01171794.